TrialPloS one2013

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).

Charlotte Charpentier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.